Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CHRISTOPHER BLIGH KOMANSKI

Allopathic & Osteopathic Physicians Ophthalmology

NPI
1558781856
CMS profile
578463
Location
ASHEVILLE, NC

General Payments · PY2018–2024

$110,839.57

  • Reported across 124 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$16,641.54

32 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Genentech USA, Inc. $14,691.90 12
Apellis Pharmaceuticals, Inc. $1,822.92 14
ABBVIE INC. $63.81 3
Regeneron Healthcare Solutions, Inc. $41.89 2
Astellas Pharma US Inc $21.02 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $150.01 3
PY2019 $576.43 3
PY2020 $1,146.66 4
PY2021 $232.34 7
PY2022 $42,246.54 35
PY2023 $49,846.05 40
PY2024 $16,641.54 32

Payment records · PY2024 (32)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $22.07 04/15/2024 Food and Beverage Undisputed 01/23/2026 1104095580 CMS
ABBVIE INC. $19.27 07/01/2024 Food and Beverage Undisputed 01/23/2026 1104095582 CMS
ABBVIE INC. $22.47 09/19/2024 Food and Beverage Undisputed 01/23/2026 1104095584 CMS
Apellis Pharmaceuticals, Inc. $1,500.00 01/23/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1154018711 CMS
Apellis Pharmaceuticals, Inc. $32.10 04/24/2024 Food and Beverage Undisputed 01/23/2026 1154018705 CMS
Apellis Pharmaceuticals, Inc. $24.24 04/29/2024 Food and Beverage Undisputed 01/23/2026 1154018701 CMS
Apellis Pharmaceuticals, Inc. $33.21 05/28/2024 Food and Beverage Undisputed 01/23/2026 1154018697 CMS
Apellis Pharmaceuticals, Inc. $23.33 06/18/2024 Food and Beverage Undisputed 01/23/2026 1154018707 CMS
Apellis Pharmaceuticals, Inc. $21.14 06/27/2024 Food and Beverage Undisputed 01/23/2026 1154018699 CMS
Apellis Pharmaceuticals, Inc. $28.11 07/11/2024 Food and Beverage Undisputed 01/23/2026 1154018703 CMS
Apellis Pharmaceuticals, Inc. $16.31 09/03/2024 Food and Beverage Undisputed 01/23/2026 1154018695 CMS
Apellis Pharmaceuticals, Inc. $22.44 09/12/2024 Food and Beverage Undisputed 01/23/2026 1154018691 CMS
Apellis Pharmaceuticals, Inc. $20.20 09/17/2024 Food and Beverage Undisputed 01/23/2026 1154018709 CMS
Apellis Pharmaceuticals, Inc. $20.20 09/26/2024 Food and Beverage Undisputed 01/23/2026 1154018693 CMS
Apellis Pharmaceuticals, Inc. $22.83 11/25/2024 Food and Beverage Undisputed 01/23/2026 1154018713 CMS
Apellis Pharmaceuticals, Inc. $29.40 12/10/2024 Food and Beverage Undisputed 01/23/2026 1154018715 CMS
Apellis Pharmaceuticals, Inc. $29.41 12/18/2024 Food and Beverage Undisputed 01/23/2026 1154018717 CMS
Astellas Pharma US Inc $21.02 07/24/2024 Food and Beverage Undisputed 01/23/2026 1139388606 CMS
Genentech USA, Inc. $101.03 01/31/2024 Food and Beverage Undisputed 01/23/2026 1132989471 CMS
Genentech USA, Inc. $322.67 04/19/2024 Travel and Lodging Undisputed 01/23/2026 1132989476 CMS
Genentech USA, Inc. $146.97 04/19/2024 Food and Beverage Undisputed 01/23/2026 1132989480 CMS
Genentech USA, Inc. $6,720.00 04/19/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1132989484 CMS
Genentech USA, Inc. $403.34 04/19/2024 Travel and Lodging Undisputed 01/23/2026 1132989488 CMS
Genentech USA, Inc. $1.49 07/02/2024 Food and Beverage Undisputed 01/23/2026 1132989492 CMS
Genentech USA, Inc. $2.79 07/02/2024 Food and Beverage Undisputed 01/23/2026 1132989496 CMS
Genentech USA, Inc. $20.04 07/02/2024 Food and Beverage Undisputed 01/23/2026 1132989500 CMS
Genentech USA, Inc. $129.41 09/18/2024 Food and Beverage Undisputed 01/23/2026 1132989508 CMS
Genentech USA, Inc. $20.98 09/19/2024 Food and Beverage Undisputed 01/23/2026 1132989504 CMS
Genentech USA, Inc. $6,720.00 10/17/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1132989512 CMS
Genentech USA, Inc. $103.18 11/29/2024 Travel and Lodging Undisputed 01/23/2026 1132989516 CMS
Regeneron Healthcare Solutions, Inc. $23.86 04/17/2024 Food and Beverage Undisputed 01/23/2026 1114090729 CMS
Regeneron Healthcare Solutions, Inc. $18.03 06/13/2024 Food and Beverage Undisputed 01/23/2026 1114090731 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.